Study Stopped
Participants were consented but registry was not developed due to low numbers
H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009
1 other identifier
observational
504
1 country
7
Brief Summary
The goal of this study it to rapidly create a brief registry of pregnant women who receive the H1N1 vaccine in Ontario, British Columbia, and Nova Scotia during the pandemic H1N1 2009/2010 influenza season.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2010
Typical duration for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 14, 2011
CompletedFirst Posted
Study publicly available on registry
June 15, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJanuary 19, 2017
January 1, 2017
3 months
June 14, 2011
January 17, 2017
Conditions
Eligibility Criteria
Pregnant women who recieved the H1N1 vaccine during pregnancy in 2009.
You may qualify if:
- Received the H1N1 vaccine during pregnancy
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dalhousie Universitylead
- Li Ka Shing Foundationcollaborator
- PHAC/CIHR Influenza Research Networkcollaborator
Study Sites (7)
Children's and Women's Health Centre, University of British Columbia
Vancouver, British Columbia, Canada
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, B3K 6R8, Canada
Queen's University
Kingston, Ontario, Canada
Li Ka Shing Knoweldge Institute
Toronto, Ontario, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre and Women's College Hospital
Toronto, Ontario, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Shelly A McNeil, MD FRCPC
Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS
- PRINCIPAL INVESTIGATOR
Joel Ray, MD FRCPC
St. Michael's Hospital/University of Toronto, Toronto, Ontario
- PRINCIPAL INVESTIGATOR
Alison McGeer, MD MSc FRCPC
Mount Sinai Hospital/University of Toronto, Toronto, Ontario
- PRINCIPAL INVESTIGATOR
Deborah Money, MD FRCSC
University of British Columbia, Vancouver, British Columbia
- PRINCIPAL INVESTIGATOR
Graeme N Smith, MD PhD FRCSC
Queen's Inversity, Kingston, Ontario
- PRINCIPAL INVESTIGATOR
Jennifer Blake, MD MSc FRCSC
Sunnybrook Health Sciences Centre and Women's College Hospital, University of Toronto
- PRINCIPAL INVESTIGATOR
Mark Yudin, MD MSc FRCSC
St. Michael's Hospital, University of Toronto, Toronto, Ontario
- PRINCIPAL INVESTIGATOR
Muhammad Mamdani, PharmD MPH
Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 14, 2011
First Posted
June 15, 2011
Study Start
April 1, 2010
Primary Completion
July 1, 2010
Study Completion
December 1, 2012
Last Updated
January 19, 2017
Record last verified: 2017-01